Joe Bonaccorso
2023
In 2023, Joe Bonaccorso earned a total compensation of $2.1M as Chief Commercial Officer at Verrica Pharmaceuticals, a 113% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,600 |
|---|---|
| Option Awards | $514,593 |
| Salary | $444,000 |
| Stock Awards | $947,500 |
| Other | $13,779 |
| Total | $2,097,472 |
Bonaccorso received $947.5K in stock awards, accounting for 45% of the total pay in 2023.
Bonaccorso also received $177.6K in non-equity incentive plan, $514.6K in option awards, $444K in salary and $13.8K in other compensation.
Rankings
In 2023, Joe Bonaccorso's compensation ranked 498th out of 2,978 executives tracked by ExecPay. In other words, Bonaccorso earned more than 83.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 498 out of 2,978 | 83rd |
Division Manufacturing | 285 out of 1,637 | 83rd |
Major group Chemicals And Allied Products | 195 out of 906 | 79th |
Industry group Drugs | 192 out of 869 | 78th |
Industry Pharmaceutical Preparations | 122 out of 627 | 81st |
Source: SEC filing on April 19, 2024.
Bonaccorso's colleagues
We found two more compensation records of executives who worked with Joe Bonaccorso at Verrica Pharmaceuticals in 2023.